Home Page Institutional - Lobe Science LTD. IR

CREATING BETTER MEDICINES FOR PATIENTS OF ALL AGES

We are a clinical stage drug development biotechnology company focused on developing transformative medicines to treat Orphan Diseases to benefit patients of all ages. We are engaged in research and development using proprietary and patent pending compounds delivered at home or in the clinic under the care and supervision of family physicians. Our team of biotech executives, collectively, have managed the development and regulatory approval of revolutionary drugs around the globe.

Get Involved

NEW PATHWAYS TOWARDS
HEALING BRAIN INJURIES.

Our Mission

There are currently no effective treatments for Chronic Cluster Headaches which afflict 100,000 patients in the United States Alone.

We plan to study the impact of treatment with L-130 on the intensity, frequency, and length of these depilating headaches.

About us

Science Driven
Solutions

Patient
Focused

We undertake to develop therapies that will deliver high levels of efficacy allowing the patients to be treated in the CLINIC or at HOME with easily administered, transformational medicines.

We have filed patents protecting our scientific discoveries and proprietary compounds and will continue to strengthen our intellectual property with new discoveries.

Patient Focused
Therapies

The Focus

Our compounds may disrupt and rewire existing communication networks within the brain to create new connectivity between brain regions. This is referred to as a “Reset”.

This brain “reset” or rewiring could be caused by the growth of dendritic spines on neurons—which represent new neural connections. (Shao et al., 2021)